IO Biotech (IOBT) Projected to Post Quarterly Earnings on Tuesday

IO Biotech (NASDAQ:IOBT) is projected to release its Q1 2025 earnings data before the market opens on Tuesday, May 13th. Analysts expect IO Biotech to post earnings of ($0.45) per share for the quarter.

IO Biotech Price Performance

IO Biotech stock opened at $1.00 on Friday. The business has a 50 day simple moving average of $0.95 and a 200-day simple moving average of $0.94. IO Biotech has a 12 month low of $0.66 and a 12 month high of $1.73. The stock has a market capitalization of $65.88 million, a PE ratio of -0.73 and a beta of 0.09.

Analysts Set New Price Targets

IOBT has been the subject of several research reports. Piper Sandler upgraded IO Biotech to a “strong-buy” rating in a research note on Wednesday, March 12th. HC Wainwright reiterated a “buy” rating and set a $12.00 price target on shares of IO Biotech in a report on Tuesday, April 1st.

IO Biotech Company Profile

IO Biotech, Inc, a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer.